Gene · 54583
Papers3,727
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1 to 20 of 3,727
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| CCN1 upregulation in diabetic wounds suppresses PINK1/Parkin-mediated mitophagy in dermal fibroblasts by regulating HIF-1α protein stability under decompensated hypoxic conditions. | Cell Signal | 2026 | 42802000 | PubTator, text mining | PubMed |
| PGC1α-mediated upregulation of PHD2 represses HIF-signaling, limiting prostate cancer progression. | Cell Death Differ | 2026 | 42754649 | PubTator, text mining | PubMed |
| Current insights into PHF14: molecular features and functional roles. | Front Mol Biosci | 2026 | 42698416 | PubTator, text mining | PubMed |
| ERN1 inhibition modifies hypoxic regulation of EGLN1 expression in U87MG glioblastoma cells. | Endocr Regul | 2026 | 42672129 | PubTator, text mining | PubMed |
| Plant-Based α-Linolenic Acid as a Superior Nutraceutical to Modulates Apoptosis, Hypoxic Signaling, and Lipid Metabolic Pathway in Breast Cancer: A Comparative Preclinical Study. | Mol Nutr Food Res | 2026 | 42671985 | PubTator, text mining | PubMed |
| Genetic Modifiers of Cardiac Remodeling Severity in IVS4+919G>A-Associated Fabry Cardiomyopathy. | Int J Mol Sci | 2026 | 42653448 | PubTator, text mining | PubMed |
| Development of endothelial injury under chemical hypoxia: early migration impairment precedes cytotoxicity in CoCl2-treated EA.hy926 cells. | Mol Biol Rep | 2026 | 42631778 | PubTator, text mining | PubMed |
| Fluoride induced chondrocyte extracellular matrix degradation by inhibition of glycolysis by the PHD2/HIF1α signaling pathway. | Environ Toxicol Pharmacol | 2026 | 42628705 | PubTator, text mining | PubMed |
Methylglyoxal Attenuates Mycobacterium avium subspecies paratuberculosis (MAP)-Induced Pro-Inflammatory Macrophage Programming Associated with NRF-2 Antioxidant Responses and Reduced MCT4/Lactate-Linked Inflammatory Markers. | Int J Mol Sci | 2026 | 42589594 | PubTator, text mining | PubMed |
| Familial erythrocytosis associated with an EGLN1 (PHD2) variant of uncertain significance with emerging evidence of pathogenicity. | BMJ Case Rep | 2026 | 42586595 | PubTator, text mining | PubMed |
| 18β-Glycyrrhetinic acid ameliorates renal anemia via inactivating PHD2 and activating HIF-2α-EPO axis. | Food Res Int | 2026 | 42562488 | PubTator, text mining | PubMed |
| Response to Letter on "Downregulation of EPAS1 and EGLN1 mRNA Expression Associated With High-Altitude Adaptive Genetic Variants in Sherpa Highlanders". | Ann Hum Genet | 2026 | 42516068 | PubTator, text mining | PubMed |
| Letter on 'Downregulation of EPAS1 and EGLN1 mRNA Expression Associated With High-Altitude Adaptive Genetic Variants in Sherpa Highlanders'. | Ann Hum Genet | 2026 | 42503878 | PubTator, text mining | PubMed |
| EXPRESSION OF CONCERN: Prolyl Hydroxylase-2 (PHD2) Exerts Tumor-Suppressive Activity in Pancreatic Cancer†. | Cancer | 2026 | 42478577 | PubTator, text mining | PubMed |
| Evolutionary convergence and niche-specific regulation of core HIF1A pathway genes synergistically drive divergent hypoxia adaptation in mammals. | BMC Ecol Evol | 2026 | 42477533 | PubTator, text mining | PubMed |
| E2F1 Drives Endothelial Arterial Programming in Pulmonary Arterial Hypertension. | bioRxiv | 2026 | 42465492 | PubTator, text mining | PubMed |
| PHD1-dependent hydroxylation of RepoMan (CDCA2) on P604 modulates the control of mitotic progression. | Elife | 2026 | 42348440 | PubTator, text mining | PubMed |
| A mechanistic computational model of the HIF signaling pathway in endothelial cells. | iScience | 2026 | 42291256 | PubTator, text mining | PubMed |
| A Mechanistic Model of the HIF-1/HIF-2 Switch Regulating Hypoxia-Induced Cancer Stemness. | Int J Mol Sci | 2026 | 42278230 | PubTator, text mining | PubMed |
| A tri-target in silico analysis of Testolift: a nutraceutical formulation targeting aromatase, myostatin, and prolyl hydroxylase-2 in testosterone regulation and muscle performance. | Sci Rep | 2026 | 42277171 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/54583/papers